Treat bacterial infections in many different parts of the body
Availability
In Stock
SIAMOX-CV 457.5, from Avosia Pharma, is a pediatric dry syrup formulation containing Amoxycillin (400 mg) and Potassium Clavulanate (57.5 mg) per 5 ml. This powerful combination provides broad-spectrum antibacterial activity against beta-lactamase-producing organisms. Amoxycillin, a penicillin-class antibiotic, targets bacterial cell wall synthesis, while Clavulanate inhibits beta-lactamase enzymes, enhancing the effectiveness of Amoxycillin against resistant strains.
Find products similar to Amoxycillin & Potassium Clavulanate Oral Suspension IP, Strength: 457 Mg
Established in the year of 2023, We “Avosia Pharma Private Limited” are Wholesale Trader and Manufacturer of an Pharmaceutical Tablets, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
